Journal article
Positioning a scientific community on unproven cellular therapies: The 2015 International Society for Cellular Therapy Perspective
Cytotherapy, Vol.17(12), pp.1663-1666
2015
Abstract
Currently, there are many unproven or insufficiently proven cell-based treatments commercially available for hopeful individuals seeking cures for a variety of conditions. Typically, these so-called “therapies” are currently being advertised, sold and administered to patients, although they fail to achieve recognized biological/medical standards of proof for safety or efficacy. In addition, they are often expensive and offered outside the cover of routine clinical care for treatments, outside the realm of conventional clinical trials supervised and monitored by regulatory agencies. This paper summarizes a position document to be published by the International Society for Cellular Therapy (ISCT) as an open manuscript intended for professionals and patient associations. Avoiding a systematic overview of the relevant peer-reviewed literature and investigations, its purpose is to examine multiple aspects of unproven cell therapy interventions including definitions, manufacturing issues, regulations, economic factors and communication. With this document, the ISCT intends to promote a cooperative approach to facilitate the development of safe and effective therapies while minimizing and balancing risks for patients to ultimately establish a coalition of stakeholders that fulfill the vision of a broad, pro-patient cell therapy alliance...
Details
- Title
- Positioning a scientific community on unproven cellular therapies: The 2015 International Society for Cellular Therapy Perspective
- Authors/Creators
- M. Dominici (Author/Creator) - University of Modena and Reggio EmiliaK. Nichols (Author/Creator) - ImmunityBio (United States)A. Srivastava (Author/Creator) - Christian Medical College, VelloreD.J. Weiss (Author/Creator) - University of VermontP. Eldridge (Author/Creator) - University of North Carolina at Chapel HillN. Cuende (Author/Creator) - Regional Government of AndalusiaR.J. Deans (Author/Creator) - Rubius Therapeutics (United States)J.E.J. Rasko (Author/Creator) - The University of SydneyA.D. Levine (Author/Creator) - Georgia Institute of TechnologyL. Turner (Author/Creator) - University of MinnesotaD.L. Griffin (Author/Creator) - Moffitt Cancer CenterL. O'Donnell (Author/Creator) - The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteM. Forte (Author/Creator) - Txcell (France)C. Mason (Author/Creator) - University College LondonE. Wagena (Author/Creator) - Wageningen University & ResearchW. Janssen (Author/Creator) - St. Jude Children's Research HospitalR. Nordon (Author/Creator) - UNSW SydneyD. Wall (Author/Creator) - The University of MelbourneH-N Ho (Author/Creator) - National Taiwan UniversityM.A. Ruiz (Author/Creator) - Beneficência Portuguesa de São PauloS. Wilton (Author/Creator) - Murdoch UniversityE.M. Horwitz (Author/Creator) - The Ohio State UniversityK.C. Gunter (Author/Creator) - Cell Medica Inc., Houston, Texas, USA
- Publication Details
- Cytotherapy, Vol.17(12), pp.1663-1666
- Publisher
- Elsevier BV
- Identifiers
- 991005540552607891
- Copyright
- © 2015 Elsevier B.V.
- Murdoch Affiliation
- Centre for Comparative Genomics
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
68 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.102 Stem Cell Research
- 1.102.110 Mesenchymal Stem Cells
- Web Of Science research areas
- Biotechnology & Applied Microbiology
- Cell & Tissue Engineering
- Cell Biology
- Hematology
- Medicine, Research & Experimental
- ESI research areas
- Biology & Biochemistry